MAGICL CK-MB (CLIA)
Intended Use
MAGICL CK-MB (CLIA) is intended for the in vitro quantitative determination of Creatine Kinase-MB (CK-MB) in human serum, plasma or whole blood samples. Clinically, it is mainly used for auxiliary diagnosis of acute myocardial infarction (AMl), myopathy diseases. For professional and laboratory use only.
Specifications
|
Product Name |
Test Item |
Method |
Sample Type |
Detection Range |
|
MAGICL CK-MB (CLIA) |
CK-MB |
Chemiluminescence Immunoassay |
Serum/Plasma/Whole Blood |
0.30-300.00 ng/mL |
|
Cut-off Value |
Test Time |
Certificates |
Storage Temperature |
Maximum Storage Time (Unopened) |
|
Female: 3.61-4.88 ng/mL; Male: 4.87-6.22 ng/mL
|
12 min |
CE, NMPA
|
2-8℃ |
Up to the stated expiration date on the label |
Applicable Device
MAGICL 6000 Chemiluminescence Immunoassay Analyzer
MAGICL 6000i Chemiluminescence Immunoassay Analyzer
MAGICL 6100 Chemiluminescence Immunoassay Analyzer
MAGICL 6200 Chemiluminescence Immunoassay Analyzer
MAGICL 6800 Chemiluminescence Immunoassay Analyzer
MAGICL 8500 Chemiluminescence Immunoassay Analyzer
MAGICL 8800 Chemiluminescence Immunoassay Analyzer
